Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?

机遇与挑战并存：在哪些情况下，微小/可测量的残留病灶可以在晚期非小细胞肺癌中发挥作用？